Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by RenovoRx, Inc.

< Previous 1 2 Next >
RenovoRx CEO Issues Update Letter to Shareholders
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment Delivery
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Announces $11.1 Million at Market Private Placement
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Highlights Key Leadership Promotions
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx CEO Issues Letter to Shareholders
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Closes $6.1 Million Private Placement
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancer
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx to Present at the ROTH MKM Healthcare Opportunities Conference on October 12, 2023
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlights
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx to Present at the 43rd Annual Canaccord Genuity Growth Conference
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform
From RenovoRx, Inc.
Via Business Wire
Tickers ASX:IMU RNXT
RenovoRx Announces New Positive Interim Phase III Data Demonstrating RenovoGem™ Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancer
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Appoints Margaret A. Tempero, M.D., to Scientific Advisory Board
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Announces ROTH Capital Key Opinion Leader (KOL) Webcast on June 15
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Initiates Patient Enrollment at University of Texas Southwestern Medical Center for Pivotal Phase III TIGeR-PaC Clinical Trial
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Announces Late-Breaking Oral Presentation at 2023 ESMO World Congress on Gastrointestinal Cancer
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx to Present at the LD Micro Invitational XIII Conference
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Reports First Quarter 2023 Financial Results and Operational Highlights
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx Sponsors Pancreatic Cancer Action Network’s PurpleStride® Event
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
RenovoRx to Participate in the Aegis Capital Virtual Conference on May 3, 2023
From RenovoRx, Inc.
Via Business Wire
Tickers RNXT
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.